SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CARDIOME PHARMA
(NQSC:CRME Last Sale: 2.3899 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (CRME : $2.3899)
$152 million Market Cap at September 12, 2013
Employs 60.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
6190 Agronomy Road Research Report Earnings Snapshot - Last 11/07/18
Vancouver, B.C., V6T 1Z3 Fact Sheet
Canada Financial Statements
Phone: (604) 677-6905 Peer Comparison
Annual Reports

Robert W. Rieder, Pres./CEO, Douglas G. Janzen, Pres., Curtis Sikorsky, CFO
Formerly NORTRAN PHARMACEUTICALS INC. Cardiovascular and respiratory applications of ion channel modulating drugs. March 17, 2008, announced positive interim clinical results from its 90-day Phase 2b study of vernakalant (oral), demonstrating statistically significant efficacy for the patient group receiving 500mg b.i.d. of vernakalant (oral) as compared to placebo. The safety data from the interim analysis also suggests that vernakalant (oral) was well-tolerated in the atrial fibrillation population studied during the dosing period under analysis.
Historical Charts    Technical Analysis
No Historical Data available for CRME

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CRME $2.3899 $ 0 $2.3 $2.56 88,310 $1.2 $2.6845 63,727
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $152,301

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
06-JUL-04 COMTF Symbol Changed to CRME
25-JUN-01 NTRDF Symbol Changed to COMTF

A2
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex